Research is being conducted on the efficacy and safety of dupilumab in treating moderate-to-severe uncontrolled asthma. The medication, also used for eczema, has shown promise in clinical trials, with some studies focusing on its use in specific populations, such as pediatric patients or those in the asia-pacific region. However, the landscape of biologic therapies for asthma is broader, with other treatments like tezepelumab also being evaluated for their safety and efficacy.